Overview Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Status: Completed Trial end date: 2008-06-01 Target enrollment: Participant gender: Summary Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis Phase: Phase 3 Details Lead Sponsor: Bausch & Lomb IncorporatedTreatments: Bepotastine besilateOphthalmic SolutionsPharmaceutical Solutions